Iradimed (IRMD) Share-based Compensation Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 5.54% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.09% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 5.29% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 7.15% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 13.40% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 12.36% |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn | 8.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.63% |
| Dec 31, 2025 | 17.74% |
| Sep 30, 2025 | 19.21% |
| Jun 30, 2025 | 82.10% |
| Mar 31, 2025 | 22.14% |
| Dec 31, 2024 | 18.76% |
| Sep 30, 2024 | 20.30% |
| Jun 30, 2024 | 19.38% |
| Mar 31, 2024 | 21.82% |
| Dec 31, 2023 | 20.13% |
| Sep 30, 2023 | 8.62% |
| Jun 30, 2023 | -40.20% |
| Mar 31, 2023 | -2.11% |
| Dec 31, 2022 | -8.04% |
| Sep 30, 2022 | -4.80% |
| Jun 30, 2022 | -36.31% |
| Mar 31, 2022 | 5.84% |
| Dec 31, 2021 | -0.88% |
| Sep 30, 2021 | -10.43% |
| Jun 30, 2021 | -6.79% |
| Mar 31, 2021 | -5.82% |
| Dec 31, 2020 | -23.83% |
| Sep 30, 2020 | -23.03% |
| Jun 30, 2020 | 81.40% |
| Mar 31, 2020 | 14.76% |
| Dec 31, 2019 | 116.77% |
| Sep 30, 2019 | 33.28% |
| Jun 30, 2019 | -27.01% |
| Mar 31, 2019 | -0.76% |
| Dec 31, 2018 | 9.45% |
| Sep 30, 2018 | 14.99% |
| Jun 30, 2018 | 12.92% |
| Mar 31, 2018 | 14.82% |
| Dec 31, 2017 | 48.38% |
| Sep 30, 2017 | 74.59% |
| Jun 30, 2017 | 38.00% |
| Mar 31, 2017 | 32.23% |
| Dec 31, 2016 | -7.47% |
| Sep 30, 2016 | 41.47% |
| Jun 30, 2016 | 160.69% |